Vancomycin-resistant enterococci

Y. Cetinkaya, P. Falk, C. G. Mayhall

Research output: Contribution to journalArticle

701 Citations (Scopus)

Abstract

After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign genetic material, they have a selective advantage over other microorganisms in the intestinal flora and pose a major therapeutic challenge. The possibility of transfer of vancomycin resistance genes to other gram-positive organisms raises significant concerns about the emergence of vancomycin-resistant Staphylococcus aureus. We review VRE, including their history, mechanisms of resistance, epidemiology, control measures, and treatment.

Original languageEnglish
Pages (from-to)686-707
Number of pages22
JournalClinical Microbiology Reviews
Volume13
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Vancomycin Resistance
Anti-Bacterial Agents
Vancomycin
Genes
Staphylococcus aureus
Epidemiology
History
Mutation
Vancomycin-Resistant Enterococci
Therapeutics
Gastrointestinal Microbiome

ASJC Scopus subject areas

  • Microbiology

Cite this

Vancomycin-resistant enterococci. / Cetinkaya, Y.; Falk, P.; Mayhall, C. G.

In: Clinical Microbiology Reviews, Vol. 13, No. 4, 2000, p. 686-707.

Research output: Contribution to journalArticle

Cetinkaya, Y, Falk, P & Mayhall, CG 2000, 'Vancomycin-resistant enterococci', Clinical Microbiology Reviews, vol. 13, no. 4, pp. 686-707. https://doi.org/10.1128/CMR.13.4.686-707.2000
Cetinkaya, Y. ; Falk, P. ; Mayhall, C. G. / Vancomycin-resistant enterococci. In: Clinical Microbiology Reviews. 2000 ; Vol. 13, No. 4. pp. 686-707.
@article{635231d331dd4282a93b039e32d219d2,
title = "Vancomycin-resistant enterococci",
abstract = "After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign genetic material, they have a selective advantage over other microorganisms in the intestinal flora and pose a major therapeutic challenge. The possibility of transfer of vancomycin resistance genes to other gram-positive organisms raises significant concerns about the emergence of vancomycin-resistant Staphylococcus aureus. We review VRE, including their history, mechanisms of resistance, epidemiology, control measures, and treatment.",
author = "Y. Cetinkaya and P. Falk and Mayhall, {C. G.}",
year = "2000",
doi = "10.1128/CMR.13.4.686-707.2000",
language = "English",
volume = "13",
pages = "686--707",
journal = "Clinical Microbiology Reviews",
issn = "0893-8512",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Vancomycin-resistant enterococci

AU - Cetinkaya, Y.

AU - Falk, P.

AU - Mayhall, C. G.

PY - 2000

Y1 - 2000

N2 - After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign genetic material, they have a selective advantage over other microorganisms in the intestinal flora and pose a major therapeutic challenge. The possibility of transfer of vancomycin resistance genes to other gram-positive organisms raises significant concerns about the emergence of vancomycin-resistant Staphylococcus aureus. We review VRE, including their history, mechanisms of resistance, epidemiology, control measures, and treatment.

AB - After they were first identified in the mid-1980s, vancomycin-resistant enterococci (VRE) spread rapidly and became a major problem in many institutions both in Europe and the United States. Since VRE have intrinsic resistance to most of the commonly used antibiotics and the ability to acquire resistance to most of the current available antibiotics, either by mutation or by receipt of foreign genetic material, they have a selective advantage over other microorganisms in the intestinal flora and pose a major therapeutic challenge. The possibility of transfer of vancomycin resistance genes to other gram-positive organisms raises significant concerns about the emergence of vancomycin-resistant Staphylococcus aureus. We review VRE, including their history, mechanisms of resistance, epidemiology, control measures, and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0033787231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033787231&partnerID=8YFLogxK

U2 - 10.1128/CMR.13.4.686-707.2000

DO - 10.1128/CMR.13.4.686-707.2000

M3 - Article

C2 - 11023964

AN - SCOPUS:0033787231

VL - 13

SP - 686

EP - 707

JO - Clinical Microbiology Reviews

JF - Clinical Microbiology Reviews

SN - 0893-8512

IS - 4

ER -